Emisphere Technologies, Inc. (OTCPK:EMIS) has now placed Eligen B12 on the market for sale. During the forth quarter of 2015, Emisphere Technologies has been approached by several major pharma and consumer healthcare companies expressing interest in licensing or acquiring the Eligen B12 product. As a result the company has concluded that it should evaluate potential strategic transactions and collaborations with these potential suitors in order to optimize the shareholders' value.